Title : Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.

Pub. Date : 2010 Feb

PMID : 20092585






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: In this 24-week study, the addition of sitagliptin to ongoing, stable-dose insulin therapy with or without concomitant metformin improved glycaemic control and was generally well tolerated in patients with type 2 diabetes. Sitagliptin Phosphate insulin Homo sapiens